Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study
1. 系统已在2025-07-30 16:05:07对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2352-3026(25)00107-3
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2352302625001073
其他信息:
出版社: Elsevier BV
作者: Rachael F Grace; Göksel Leblebisatan; Yesim Aydinok; Şule Ünal; John D Grainger; Jessica Zhang; Linda Smallwood; Emily de León; Brian D Jamieson; Rachael F Grace; Göksel Leblebisatan; Yesim Aydinok; Sule Ünal; John D Grainger; Waseem Alhushki; Emma J Astwood; Philip Connor; Elena Donyush; Veronika Dudnyk; Stephanie A Fritch-Lilla; John Grainger; Amanda B Grimes; Peter Hauser; Susanne Holzhauer; Loan B Hsieh; Zeynep Karakas; Gabor Kovacs; Osman Alphan Kupesiz; Andrzej Kurylak; Pawel Laguna; Wojciech Mlynarski; Jayashree Motwani; Gabor Ottoffy; Marlene Pasquet; Olga Plaksina; Nataliia Popova; Melissa J Rose; Jessica Sandham; Corinna L Schultz; Keith Sibson; Brigitte Strahm; Selma Unal; Selin Yakarisik; Mehmet Akif Yesilipek
